Nantahala Capital Management, LLC 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:54 pm Purchase | 2025-09-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Nantahala Capital Management, LLC | 1,235,000 9.390% | 335,000 (+37.22%) | Filing |
| 2025-05-15 4:36 pm Purchase | 2025-03-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Nantahala Capital Management, LLC | 900,000 8.430% | 857,900 (+2037.77%) | Filing |